DEVELOPMENT AND VALIDATION OF A GREEN BIOANALYTICAL METHOD FOR THE DETERMINATION OF SPARFLOXACIN IN PHARMACEUTICAL DOSAGE FORM AND HUMAN PLASMA BY RP-HPLC
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2016, Vol 7, Issue 6
Abstract
This study describes the development of an innovative, green, rapid, precise, selective and sensitive reverse phase high-performance liquid chromatography method for the quantitative determination of Sparfloxacin (SPR) in human plasma and pharmaceutical dosage form. Extraction of drug from plasma was done by employing optimized liquid-liquid extraction procedure. The sample was analyzed using Methanol: Water (pH-7 with triethylamine) (60:40 % v/v) as mobile phase. Chromatographic separation was achieved on Prontosil C-18 column (4.6 x 250mm, 5μ particle size) as stationary phase using isocratic elution (at a flow rate of 1 ml/min). The peak was detected using UV-PDA detector set at 254 nm and the total time for a chromatographic separation was 9 min. The calibration curve obtained was linear (r2= 0.9998) over the concentration range of 5-25μg/ml. Method was validated for precision, robustness and recovery. The limit of detection (LOD) and limit of quantitation (LOQ) was 0.573 and 1.542 µg/ml respectively. There was no significant difference between the amount of drug spiked in plasma and the amount recovered and plasma did not interfere in estimation. Other important factors is that the method uses less amounts of organic solvent, produces low levels of waste and does not use buffer solution, minimizing effluent treatment, which contributes to the environment and implements methods aimed green chemistry, making economic for the industry. Thus, the proposed method is suitable for the analysis of SPR in tablet dosage forms and human plasma.
Authors and Affiliations
Nilesh Jain , Ruchi Jain , Deepak Jain , Vijay Patel , Surendra Jain
Keywords
Related Articles
- EP ID EP101753
- DOI 10.7897/2230-8407.07671
- Views 104
- Downloads 0
RNAi THERAPEUTICS
RNA interference (RNAi) was discovered less than a decade ago and already there are human clinical trials in progress or planned. A major advantage of RNAi versus other antisense based approaches for therapeutic applicat...
CLINICAL EVALUATION OF KODIPAVALA CHUNNAM IN THE TREATMENT OF INFECTIVE HEPATITIS, DRUG INDUCED HEPATITIS AND ALCOHOLIC HEPATITIS
The present clinical study was carried out to validate the efficacy and safety of Siddha Herbo- mineral formulation ‘Kodipavala Chunnam’ in the treatment of Infective hepatitis, Drug induced hepatitis and Alcoholic hepat...
SIMULTANEOUS SPECTROPHOTOMETRIC DETERMINATION OF CEFIXIME TRIHYDRATE AND OFLOXACIN IN TABLETS
The present manuscript describe simple, sensitive, rapid, accurate, precise and economical Q-absorbance ratio method for the simultaneous determination of cefixime trihydrate and ofloxacin in combined tablet dosage form....
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF CAPECITABINE IN BULK BY RP-HPLC METHOD
A simple, rapid and selective RP-HPLC method has been developed for quantification of Capecitabine from bulk drug using a mobile phase consisting mixture of methanol and buffer (70:30) (v/v) at the flow rate of 1.0 ml/mi...
BENZIMIDAZOLE: AS POTENTIAL BIOLOGICALLY ACTIVE AGENT
The benzimidazole ring system is an important pharmacophore in medicinal chemistry and modern drug discovery. Benzimidazole and its derivatives are used in organic synthesis and they are used in evaluating new product th...